Siriuspoint Ltd

Siriuspoint Ltd (SPNT) Stock Analysis

$24.870

-0.393 (-1.58%)At close

Loading chart…
High
25.720
Open
25.600
VWAP
25.10
Volume
1.13M
Mkt Cap
2.10B
Low
24.720
Amount
28.46M
EV/EBITDA, TTM
6.37

SiriusPoint Ltd. is a Bermuda-based global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. The Company has licenses to write property and casualty and accident and health insurance and reinsurance globally. The Company’s segments include Reinsurance and Insurance & Services. In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk-bearing vehicles on a treaty or facultative basis. The Reinsurance segment predominantly underwrites casualty, property and specialty lines of business on a worldwide basis. For reinsurance assumed, it participates in the reinsurance market with a global focus through the broker market distribution channel. Through the Insurance & Services segment, the Company underwrites primary insurance in a number of sectors. The Insurance & Services segment includes accident and health, casualty, and specialty.

AI analysis of Siriuspoint Ltd (SPNT)

Buy

Siriuspoint Ltd (SPNT) is a good buy right now, trading at $24.96 with a forward P/E of 9.23, indicating potential undervaluation. Analyst targets suggest a price increase of 20% to 31%, with RBC Capital setting a target of $30 and B. Riley at $31. The company's recent performance shows a 32.70% increase over the past year, alongside a solid RSI of 60.35, indicating bullish momentum. However, the main risk is the recent earnings miss, where EPS of $0.58 fell short of the $0.65 estimate, which could impact short-term sentiment.

Valuation Metrics

The current forward P/E ratio for Siriuspoint Ltd (SPNT) is 9.23, compared to its 5-year average forward P/E of 4.06.

Forward P/E

Overvalued
5Y Average P/E
4.06
Current P/E
9.23
Overvalued
7.89
Undervalued
0.23

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
0.87
Current EV/EBITDA
6.37
Overvalued
2.91
Undervalued
-1.17

Forward P/S

Fair
5Y Average P/S
0.79
Current P/S
0.90
Overvalued
1.69
Undervalued
-0.12

Whales holding SPNT

G

Gilder Gagnon Howe & Co. LLC

+ HoldingSPNT

+6.79%

3M Return

D

Donald Smith & Co., Inc.

+ HoldingSPNT

-3.34%

3M Return

T

Third Point LLC

+ HoldingSPNT

-3.59%

3M Return

P

Punch & Associates Investment Management, Inc.

+ HoldingSPNT

-4.57%

3M Return

P

Private Management Group Inc

+ HoldingSPNT

-4.74%

3M Return

Events Timeline

2026-09-15 (ET)

16:30:00

SiriusPoint Appoints Rachel Winoski as Chief Human Resources Officer

2026-07-29 (ET)

17:00:00

Company Reports Q2 Revenue of $744.1M

16:31:00

Scott Egan: Q2 Revenue $744.1 Million

2026-07-16 (ET)

16:30:00

SiriusPoint Appoints Emily Yoo as COO

2026-03-16 (ET)

07:40:00

SiriusPoint Restructures Business into Four Divisions

News

SPNT FAQ — answered by Alphio AI

SiriusPoint Ltd. is a Bermuda-based global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. The Company has licenses to write property and casualty and accident and health insurance and reinsurance globally. The Company’s segments include Reinsurance and Insurance & Services. In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk-bearing vehicles on a treaty or facultative basis. The Reinsurance segment predominantly underwrites casualty, property and specialty lines of business on a worldwide basis. For reinsurance assumed, it participates in the reinsurance market with a global focus through the broker market distribution channel. Through the Insurance & Services segment, the Company underwrites primary insurance in a number of sectors. The Insurance & Services segment includes accident and health, casualty, and specialty. It operates in the Financials sector (FIRE, MARINE & CASUALTY INSURANCE industry).

Siriuspoint Ltd (SPNT) is a good buy right now, trading at $24.96 with a forward P/E of 9.23, indicating potential undervaluation. Analyst targets suggest a price increase of 20% to 31%, with RBC Capital setting a target of $30 and B. Riley at $31. The company's recent performance shows a 32.70% increase over the past year, alongside a solid RSI of 60.35, indicating bullish momentum. However, the main risk is the recent earnings miss, where EPS of $0.58 fell short of the $0.65 estimate, which could impact short-term sentiment.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading